.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Citi
UBS
Boehringer Ingelheim
Queensland Health
Baxter
AstraZeneca
QuintilesIMS
Cerilliant

Generated: July 23, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Primary aminoacylanilides
Abstract:Primary amino acylanilides of the formula ##STR1## wherein R.sub.1 is selected from the group consisting of hydrogen, methyl, ethyl and propyl, R.sub.2 is selected from the group consisting of methyl, ethyl, chlorine, methoxy and ethoxy, R.sub.3 is selected from the group consisting of hydrogen and methyl, R.sub.4 is selected from the group consisting of hydrogen, methyl, and a C.sub.1 -C.sub.4 alkoxy group, R.sub.6 is selected from the group consisting of methyl, ethyl, chlorine, methoxy and ethoxy, R.sub.7 is hydrogen, methyl or ethyl, R.sub.8 is hydrogen, R.sub.9 is hydrogen, methyl or ethyl, R.sub.10 is hydrogen, and n is 0 or 1, with the provisions that (a) when n is 0, R.sub.8 can also be methyl; (b) when n is 1, and R.sub.7 is hydrogen, and R.sub.9 is hydrogen or methyl, then R.sub.10 can also be methyl; (c) when R.sub.1 is hydrogen, R.sub.2 is methyl, R.sub.3 is hydrogen, R.sub.6 is methyl, R.sub.7 is hydrogen, R.sub.8 is hydrogen, and n is 0, then R.sub.4 can be ethoxy or propoxy only; (d) when R.sub.1 is hydrogen, R.sub.2 is methyl, R.sub.3, R.sub.4, R.sub.7 and R.sub.8 are hydrogen, and n is 0, then R.sub.6 is methoxy, ethoxy, or ethyl only; and the therapeutically acceptable salts thereof. Compounds of this type have been found to be effective longlasting cardiac antiarrhythmic agents, especially when administered by the oral route.
Inventor(s): Boyes; Robert N. (Auburn, MA), Duce; Benjamin R. (Westborough, MA), Smith; Emil R. (Shrewsbury, MA), Byrnes; Eugene W. (Holden, MA)
Assignee: Astra Pharmaceutical Products, Inc. (Worcester, MA)
Application Number:05/929,916
Patent Claims: 1. The compound 2-amino-2',6'-propionoxylidide, and the pharmaceutically acceptable salts thereof.

2. The compound (+)-2-amino-2',6'-propionoxylidide, and the pharmaceutically acceptable salts thereof.

3. The compound (-)-2-amino-2',6'-propionoxylidide, and the pharmaceutically acceptable salts thereof.

4. The compound 2-amino-2'-ethyl-6'-methylpropionanilide, and the pharmaceutically acceptable salts thereof.

5. The compound 3-amino-2',6'-butyroxylidide, and the pharmaceutically acceptable salts thereof.

6. The compound 2-amino-2',6'-diethylpropionanilide, and the pharmaceutically acceptable salts thereof.

7. The compound 3-amino-2',4',6'-propionomesidide, and the pharmaceutically acceptable salts thereof.

8. The compound 2-amino-4'-butoxy-2',6'-dimethylpropionanilide, and the pharmaceutically acceptable salts thereof.

9. The compound 3-amino-2'-methyl-6'-ethylbutyranilide, and the pharmaceutically acceptable salts thereof.

10. The compound 3-amino-2',4',6'-butyromesidide, and the pharmaceutically acceptable salts thereof.

11. The compound 3-amino-2',6'-valeroxylidide, and the pharmaceutically acceptable salts thereof.

12. The compound 3-amino-2',6'-propionoxylidide and the pharmaceutically acceptable salts thereof.

13. The compound 2-amino-2',6'-butyroxylidide and the pharmaceutically acceptable salts thereof.

14. The compound 3-amino-2-methyl-2',6'-propionoxylidide and the pharmaceutically acceptable salts thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
US Department of Justice
Boehringer Ingelheim
Harvard Business School
Citi
Medtronic
Baxter
Chubb
Federal Trade Commission
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot